Page last updated: 2024-08-24

gemcitabine and sclareolide

gemcitabine has been researched along with sclareolide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Dong, MS; Wang, Y; Zhang, JH; Zhang, WL	1

Other Studies

1 other study(ies) available for gemcitabine and sclareolide

Article	Year
Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer. Molecular medicine reports, 2017, Volume: 15, Issue:4 Topics: Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Diterpenes; Down-Regulation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Equilibrative Nucleoside Transporter 1; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Pancreatic Neoplasms; Phenotype; Receptors, Notch; Ribonucleoside Diphosphate Reductase; Signal Transduction; Tumor Suppressor Proteins; Up-Regulation; Zinc Finger Protein GLI1	2017

Article

Year

Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.

Molecular medicine reports, 2017, Volume: 15, Issue:4

Topics: Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Diterpenes; Down-Regulation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Equilibrative Nucleoside Transporter 1; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Pancreatic Neoplasms; Phenotype; Receptors, Notch; Ribonucleoside Diphosphate Reductase; Signal Transduction; Tumor Suppressor Proteins; Up-Regulation; Zinc Finger Protein GLI1

2017